KURT W BRINER Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for KURT W BRINER.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of KURT W BRINER. KURT W BRINER is a Director in PROGENICS PHARMACEUTICALS INC ($PGNX) and a Director in BioAmber Inc. ($BIOAU).

Address: 6, RUE SAINT-JOSEPH 1227 CAROUGE 99999Switzerland

Companies in which KURT W BRINER is an Insider

BioAmber Inc.

Trading Symbol: BIOA
Industry: INDUSTRIAL ORGANIC CHEMICALS [2860]
Position of KURT W BRINER: Director
Holdings: 285,978 shares
Latest Transaction: Aug 16 2017

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PROGENICS PHARMACEUTICALS INC

Trading Symbol: PGNX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KURT W BRINER: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 06 2004
$PGNX Market Capitalization: $671.09M
$PGNX Previous Close: $9.53

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of KURT W BRINER

Sentiment: All, BIOA, PGNX

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 16 2017BIOAUBioAmber Inc.BRINER KURT WDirectorOption ExerciseP0.75133,333100,000133,333
Aug 16 2017BIOAUBioAmber Inc.BRINER KURT WDirectorBuyP0.00133,3330285,978152.6 K to 286 K (+87.35 %)
May 17 2017BIOAUBioAmber Inc.BRINER KURT WDirectorOption ExerciseA2.2636,00081,36036,000
Nov 10 2016BIOAUBioAmber Inc.BRINER KURT WDirectorBuyP3.8410,00038,415152,645142.6 K to 152.6 K (+7.01 %)
May 26 2016BIOAUBioAmber Inc.BRINER KURT WDirectorBuyP3.691,0003,691142,645141.6 K to 142.6 K (+0.71 %)
May 24 2016BIOAUBioAmber Inc.BRINER KURT WDirectorBuyP3.708,91532,979141,645132.7 K to 141.6 K (+6.72 %)
May 24 2016BIOAUBioAmber Inc.BRINER KURT WDirectorBuyP3.5412,10042,790132,730120.6 K to 132.7 K (+10.03 %)

View all KURT W BRINER insider transactions.